These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 14393802)
1. Oxychlorine in cytostatic therapy of malignant blood diseases. CONSOLI G Minerva Med; 1955 May; 46(39):1386-8. PubMed ID: 14393802 [No Abstract] [Full Text] [Related]
2. [Nitrogen mustards and derivative substances; their use in therapy of blood diseases]. CAPORALETTI I Prog Med (Napoli); 1954 Oct; 10(19):587-96. PubMed ID: 13215604 [No Abstract] [Full Text] [Related]
3. [Oxygenated nitrogen mustards in the therapy of malignant blood diseases]. CONSOLI G Gazz Med Ital; 1954 Dec; 113(12):359-97. PubMed ID: 14366192 [No Abstract] [Full Text] [Related]
4. [Treatment of hemoblastosis and personal experiences with nitrogen mustard]. SOFTIC N Med Arh; 1953; 7(5):69-87. PubMed ID: 13144100 [No Abstract] [Full Text] [Related]
5. [Experiences in nitrogen mustard therapy of the blood diseases]. TOSZEGI A Magy Belorv Arch Ideggyogy Szle; 1952 Mar; 5(1):7-11. PubMed ID: 13118919 [No Abstract] [Full Text] [Related]
6. [Use of microdoses of nitrogen mustards]. FOIT R; SIEBEROVA R Cas Lek Cesk; 1952 Mar; 91(13):382-6. PubMed ID: 14390177 [No Abstract] [Full Text] [Related]
7. [Clinical experiences with rest nitrogen phosphamide esters in hemopathies]. BRICHTA G; KUHBOCK J; REIMER EE Wien Z Inn Med; 1958 Jul; 39(7):306-11. PubMed ID: 13604281 [No Abstract] [Full Text] [Related]
8. [Therapy of malignant diseases of the lymphatic and reticular systems with a nitrogen mustard derivative]. ZULIK R Arzneimittelforschung; 1958 Jun; 8(6):360-1. PubMed ID: 13546105 [No Abstract] [Full Text] [Related]
9. [Cytostatic drugs in the treatment of malignant tumors; clinical experiences with mitomen]. APEL G; KLAGES K Medizinische; 1957 Mar; (9):314-8. PubMed ID: 13430178 [No Abstract] [Full Text] [Related]
10. [Malignant lymphogranulomatosis (Hodgkin's diseases) with cutaneous initiation: total remission under combined treatment with radio-therapy and nitrogen mustard]. CORDIVIOLA LA; BOSQ P; ROSSELLI S Prensa Med Argent; 1954 Feb; 41(8):522-5. PubMed ID: 13155404 [No Abstract] [Full Text] [Related]
11. [Clinical experiences and experimental studies with the cytostatic nitrogen mustard oxide in surgery]. HENNE HF; MARGGRAF W Strahlentherapie; 1957; 15(Sonderbd. 37):281-3. PubMed ID: 13495779 [No Abstract] [Full Text] [Related]
12. [Range of indication for nitrogen mustard oxide in the therapy of malignant tumors]. BECKER T Strahlentherapie; 1957; 15(Sonderbd. 37):279-80. PubMed ID: 13495778 [No Abstract] [Full Text] [Related]
13. [Regression of a metastasizing disgerminoma by cytostatic drug therapy]. THEISEN H Geburtshilfe Frauenheilkd; 1959 Mar; 19(3):252-6. PubMed ID: 13640218 [No Abstract] [Full Text] [Related]
14. [Clinical experiences and experimental studies with the cytostatic nitrogen mustard oxide in gynecology]. VASTERLING HW; HALFPAP E Strahlentherapie; 1957; 15(Sonderbd. 37):283-4. PubMed ID: 13495780 [No Abstract] [Full Text] [Related]
15. [Contributions on nitrogen therapy. III. Combined nitrogen mustard & cortison therapy of kidney diseases]. ERLSBACHER O; POPP A; GEISBERGER H Klin Med Osterr Z Wiss Prakt Med; 1957 May; 12(5):193-7. PubMed ID: 13439901 [No Abstract] [Full Text] [Related]
16. [Nitrogen mustard therapy of malignant granuloma, leukemia and neoplasms]. INGRASSIA G; VASILE B Haematologica; 1951; 35(10):907-53. PubMed ID: 14906882 [No Abstract] [Full Text] [Related]
17. [Clinical experiences with nitrogen mustards. V. Therapy of malignant tumors]. CERNIK F; LUKL P; PROCHAZKA J; VIZDA J Cas Lek Cesk; 1952 Jan; 91(2):44-9. PubMed ID: 14390080 [No Abstract] [Full Text] [Related]
18. The role of nitrogen mustard in the palliation of malignant disease with particular reference to pain. NEWSOME JF Am Surg; 1958 Sep; 24(9):651-7. PubMed ID: 13571615 [No Abstract] [Full Text] [Related]
19. [Testing of some N-lost-compounds by screening test for cytostatic activity (author's transl)]. Keitel R; Pöge AW Arch Geschwulstforsch; 1974; 43(2):168-71. PubMed ID: 4849880 [No Abstract] [Full Text] [Related]
20. The primary effects of nitromin on malignant diseases. NASR AL; AWAD H J Egypt Med Assoc; 1954; 37(7):733-53. PubMed ID: 13233400 [No Abstract] [Full Text] [Related] [Next] [New Search]